Viropro Operating Margin from 2010 to 2026
Viropro Operating Profit Margin yearly trend continues to be very stable with very little volatility. Operating Profit Margin is likely to drop to -1.65.
Check out the analysis of Viropro Correlation against competitors. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.
Check Viropro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viropro's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1 M or Total Revenue of 689.6 K, as well as many indicators such as Price To Sales Ratio of 2.37, Dividend Yield of 0.0 or PTB Ratio of 0.8. Viropro financial statements analysis is a perfect complement when working with Viropro Valuation or Volatility modules.
Viropro | Operating Margin | Build AI portfolio with Viropro Stock |
Evaluating Viropro's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Viropro's fundamental strength.
Latest Viropro's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Viropro over the last few years. It is Viropro's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Viropro's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (2.09) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Viropro Operating Margin Regression Statistics
| Arithmetic Mean | (2.02) | |
| Coefficient Of Variation | (60.00) | |
| Mean Deviation | 0.55 | |
| Median | (1.74) | |
| Standard Deviation | 1.21 | |
| Sample Variance | 1.47 | |
| Range | 5.1564 | |
| R-Value | 0.43 | |
| Mean Square Error | 1.28 | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | 0.10 | |
| Total Sum of Squares | 23.55 |
Viropro Operating Margin History
About Viropro Financial Statements
Viropro investors utilize fundamental indicators, such as Operating Margin, to predict how Viropro Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. VIROPRO INC operates under Biotechnology classification in the United States and is traded on PNK Exchange.
Pair Trading with Viropro
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Viropro position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viropro will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Viropro could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Viropro when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Viropro - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Viropro to buy it.
The correlation of Viropro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viropro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viropro moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Viropro can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Viropro Correlation against competitors. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Biotechnology sector continue expanding? Could Viropro diversify its offerings? Factors like these will boost the valuation of Viropro. If investors know Viropro will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Viropro data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Revenue Growth 1.19 |
Understanding Viropro requires distinguishing between market price and book value, where the latter reflects Viropro's accounting equity. The concept of intrinsic value - what Viropro's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Viropro's price substantially above or below its fundamental value.
Please note, there is a significant difference between Viropro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viropro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Viropro's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.